Patent details

EP4212152 Title: SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING CHRONIC SYSTOLIC HEART FAILURE

Basic Information

Publication number:
EP4212152
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP231547571
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING CHRONIC SYSTOLIC HEART FAILURE
French Title of Invention:
SCHÉMA POSOLOGIQUE DU SACUBUTRIL-VALSARTAN POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE SYSTOLIQUE CHRONIQUE
German Title of Invention:
SACUBITRIL-VALSARTAN DOSIERSCHEMA ZUR BEHANDLUNG VON CHRONISCHEM SYSTOLISCHEM HERZVERSAGEN
SPC Number:

Dates

Filing date:
09/05/2016
Grant date:
30/04/2025
EP Publication Date:
19/07/2023
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/04/2025
EP B1 Publication Date:
30/04/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/05/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/04/2025
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
02/06/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CHEN, Fabian
Address:
United States (US)

2

Name:
SHI, Victor Chengwei
Address:
United States (US)

3

Name:
RIZKALA, Adel Redmond
Address:
United States (US)

Priority

Priority Number:
201562159703 P
Priority Date:
11/05/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/225; A61K 31/41; A61P 9/04;

Publication

European Patent Bulletin

1

Issue number:
202518
Publication date:
30/04/2025
Description:
Grant (B1)

2

Issue number:
202523
Publication date:
04/06/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/06/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
02/06/2025 Power Of Attorney 1
02/06/2025 Outgoing Correspondence 1